EU says no final decision taken on ending Valneva COVID vaccine contract

1 minute read

Valneva logo is seen displayed in this illustration taken, May 3, 2022. REUTERS/Dado Ruvic/Illustration/File Photo

Register now for FREE unlimited access to Reuters.com

BRUSSELS, May 16 (Reuters) - The European Commission said on Monday that no final decision had been made about the possible termination of a contract with Valneva (VLS.PA) to supply its COVID-19 vaccine to the European Union.

Valneva said earlier on Monday it had received a notice of intent from the Commission to terminate the contract. The statement triggered a sell-off of the company's shares, which lost one-fifth of their value in few hours. read more

EU Commission spokesman Stefan de Keersmaecker confirmed the EU executive had communicated to Valneva its intention to terminate the contract but said the final decision would only be made after consulting with Valneva on the matter.

Register now for FREE unlimited access to Reuters.com

He told a regular news briefing that the notice had been sent after an agreement with EU governments, but said the notice was only the start of a process.

Valneva can now propose alternative solutions and only after that would the EU decide whether to terminate the contract, the spokesman said, adding that the EU "will consider any remedial solution the company may propose".

Under the deal, Valneva had agreed to supply up to 60 million doses of vaccine over two years.

Register now for FREE unlimited access to Reuters.com
Reporting by Francesco Guarascio @fraguarascio; Editing by Jason Neely and Edmund Blair

Our Standards: The Thomson Reuters Trust Principles.